Caffeinol at the receptor level: anti-ischemic effect of N-methyl-D-aspartate receptor blockade is potentiated by caffeine
about
Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research.Developmental neurotoxicity of alcohol and anesthetic drugs is augmented by co-exposure to caffeine.Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation?The influence of stroke risk factors and comorbidities on assessment of stroke therapies in humans and animals.Caffeine and cardiovascular diseases: critical review of current research.
P2860
Caffeinol at the receptor level: anti-ischemic effect of N-methyl-D-aspartate receptor blockade is potentiated by caffeine
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Caffeinol at the receptor leve ...... ade is potentiated by caffeine
@ast
Caffeinol at the receptor leve ...... ade is potentiated by caffeine
@en
type
label
Caffeinol at the receptor leve ...... ade is potentiated by caffeine
@ast
Caffeinol at the receptor leve ...... ade is potentiated by caffeine
@en
prefLabel
Caffeinol at the receptor leve ...... ade is potentiated by caffeine
@ast
Caffeinol at the receptor leve ...... ade is potentiated by caffeine
@en
P2093
P2860
P1433
P1476
Caffeinol at the receptor leve ...... ade is potentiated by caffeine
@en
P2093
James C Grotta
Jaroslaw Aronowski
Paisith Piriyawat
Robert Palusinski
Roger Strong
Xiurong Zhao
P2860
P304
P356
10.1161/STROKEAHA.109.562900
P407
P577
2009-12-31T00:00:00Z